Skip to main content
. Author manuscript; available in PMC: 2015 Sep 8.
Published in final edited form as: Cancer Chemother Pharmacol. 2011 Jun 5;69(1):185–194. doi: 10.1007/s00280-011-1684-y

Fig. 4.

Fig. 4

Flow cytometric analysis of DNA content in the RCC cell lines 786-O and CAKI-1. Cells were treated with 5 mM perifosine and/or 10 nM rapamycin. Graphed are the results for 786-O cells treated for (a) 24 h and (b) 72 h and CAKI-1 cells treated for (c) 24 h and (d) 72 h. SubG1 content is represented in the upper component of each graph